GE has patented a process that could help plant biologists predict and reduce the risk of human deaths from plant diseases.
The new process, dubbed Fertility Awareness Technology, or FAT, involves inserting DNA from a virus into plant DNA and then growing the DNA on plants.
The technology could help scientists predict and treat the disease that kills more than 400,000 people a year in the United States.
The company is developing the technology in partnership with University of Washington scientists, who are also working with the University of Texas Medical Branch to develop an Ebola vaccine.FAT uses DNA from an Ebola virus gene to be inserted into a plant.
That DNA can be manipulated to trigger the plant’s DNA to produce new proteins that could prevent the plant from contracting the disease.
It could also reduce the rate of plant death.
The FDA is currently considering the patent application.
The U.S. Food and Drug Administration approved a version of FAT in February 2016.
The FDA is evaluating applications for the technology for human use, the company said in a statement.
The company also said it is working with a U.K. company, Bioscience, to develop a human-controlled vaccine to treat Ebola.
The U.KS.-based company also has patents on a vaccine that is being tested in Africa.
The American public can participate in the FDA’s Ebola response, and the agency has approved the use of the vaccine to help control the disease in Liberia.
The agency is also exploring other ways to help the United Nations fight Ebola.